Revanor Trademark Details

This mark is dead with a status of Abandoned - After Publication. The last case file activity for this mark occured 16 years ago on Monday, June 4, 2007, according to the United State Patent & Trademark Office
Word Mark Revanor
Status Dead 605 — Abandoned - After Publication

Current Owner

Forest Laboratories, Inc. of New York, NY

View all trademarks for Forest Laboratories, Inc.
Other Trademarks for Forest Laboratories, Inc.
Serial Number 77059469
Status Date Monday, June 4, 2007
Filing Date Monday, June 4, 2007
Attorney Christopher Serbagi

Correspondent

CHRISTOPHER SERBAGI
LAW OFFICES OF CHRISTOPHER SERBAGI
488 MADISON AVE STE 1120
NEW YORK, NY 10022-5719

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment of hypertension, isolated systolic hypertension, essential hypertension, hypertension with renal disease, primary pulmonary hypertension, hypertension encephalopathy, congestive heart failure, diastolic heart failure, peripheral vascular disease, left ventricular dysfunction following myocardial infarction, definite or suspected acute myocardial infarction, angina pectoris, chest pain, neuropathy in Type II diabetics, endothelial dysfunction, coronary artery disease, chronic ischemic disease, atrial fibrillation and flutter, coronary atherosclerosis, atherosclerotic renal arteries, diabetes with renal manifestations, mitral valve disorders, aortic valve disorders, tachycardia, cardiac dysrhythmias, primary cardiomyopathy, metabolic syndrome, pulmonary valve disorder, migraine, and for the prevention of migraine

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 8 — Abandoned
Status Date Monday, June 4, 2007
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.